Entyvio (Vedolizumab) Long Term Safety Study

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

A Safety Extension Study of SHP647 in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission

Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

An Efficacy and Safety Study of SHP647 as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis

Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

BI 655130 Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis